BIOMAT Database Logo BIOMAT Database Logo

Prospective randomized double-blind trial of 3 versus 6 months of nafarelin therapy for endometriosis associated pelvic pain. 1995

M D Hornstein, and A A Yuzpe, and K A Burry, and L R Heinrichs, and V L Buttram, and E S Orwoll
Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.

OBJECTIVE To determine the effectiveness of a 3-month course of nafarelin and, furthermore, to determine the long-term efficacy in patients treated for 3 and 6 months with nafarelin for symptoms associated with endometriosis. METHODS Double-blind, prospective, multicenter, clinical trial. METHODS Fifteen reproductive endocrine clinics throughout the United States. METHODS One hundred seventy-nine women with pelvic pain and endometriosis. METHODS Patients were assigned randomly to 3 months nafarelin followed by 3 months of placebo (n = 91) or to 6 months nafarelin (n = 88) in a prospective, randomized, double-blind multicenter trial. Patients were followed for 12 months after cessation of therapy. METHODS Patient-reported pain scores and physician-reported physical exam findings. RESULTS Pain scores dropped significantly by the end of treatment in both groups. Symptoms recurred in both groups, and pain scores gradually increased during the follow-up period but always remained below baseline in both groups. No significant difference in efficacy was noted between the groups. A total of 26% of patients in each group underwent retreatment for recurrent symptoms. CONCLUSIONS A 3-month course of nafarelin provided effective symptom relief for endometriosis. One year follow-up demonstrated continued pain relief but with gradual return of symptoms.

UI MeSH Term Description Entries
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004715 Endometriosis A condition in which functional endometrial tissue is present outside the UTERUS. It is often confined to the PELVIS involving the OVARY, the ligaments, cul-de-sac, and the uterovesical peritoneum. Endometrioma,Endometriomas,Endometrioses
D004958 Estradiol The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids. 17 beta-Estradiol,Estradiol-17 beta,Oestradiol,17 beta-Oestradiol,Aerodiol,Delestrogen,Estrace,Estraderm TTS,Estradiol Anhydrous,Estradiol Hemihydrate,Estradiol Hemihydrate, (17 alpha)-Isomer,Estradiol Monohydrate,Estradiol Valerate,Estradiol Valeriante,Estradiol, (+-)-Isomer,Estradiol, (-)-Isomer,Estradiol, (16 alpha,17 alpha)-Isomer,Estradiol, (16 alpha,17 beta)-Isomer,Estradiol, (17-alpha)-Isomer,Estradiol, (8 alpha,17 beta)-(+-)-Isomer,Estradiol, (8 alpha,17 beta)-Isomer,Estradiol, (9 beta,17 alpha)-Isomer,Estradiol, (9 beta,17 beta)-Isomer,Estradiol, Monosodium Salt,Estradiol, Sodium Salt,Estradiol-17 alpha,Estradiol-17beta,Ovocyclin,Progynon-Depot,Progynova,Vivelle,17 beta Estradiol,17 beta Oestradiol,Estradiol 17 alpha,Estradiol 17 beta,Estradiol 17beta,Progynon Depot
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D017274 Nafarelin A potent synthetic agonist of GONADOTROPIN-RELEASING HORMONE with 3-(2-naphthyl)-D-alanine substitution at residue 6. Nafarelin has been used in the treatments of central PRECOCIOUS PUBERTY and ENDOMETRIOSIS. Nafarelin Acetate,Nafarelin Acetate, Hydrate,Nafarelin Monoacetate,RS-94991-298,Synarel,RS 94991 298,RS94991298

Related Publications

M D Hornstein, and A A Yuzpe, and K A Burry, and L R Heinrichs, and V L Buttram, and E S Orwoll
Linzagolix therapy versus a placebo in patients with endometriosis-associated pain: a prospective, randomized, double-blind, Phase 3 study (EDELWEISS 3).
April 2024, Human reproduction (Oxford, England),
M D Hornstein, and A A Yuzpe, and K A Burry, and L R Heinrichs, and V L Buttram, and E S Orwoll
Prospective, randomized, double-blind, controlled trial of laser laparoscopy in the treatment of pelvic pain associated with minimal, mild, and moderate endometriosis.
October 1994, Fertility and sterility,
M D Hornstein, and A A Yuzpe, and K A Burry, and L R Heinrichs, and V L Buttram, and E S Orwoll
A double-blind randomized study of the treatment of endometriosis with nafarelin or nafarelin plus norethisterone.
June 1997, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology,
M D Hornstein, and A A Yuzpe, and K A Burry, and L R Heinrichs, and V L Buttram, and E S Orwoll
Adjuvant use of melatonin for pain management in endometriosis-associated pelvic pain-A randomized double-blinded, placebo-controlled trial.
January 2023, PloS one,
M D Hornstein, and A A Yuzpe, and K A Burry, and L R Heinrichs, and V L Buttram, and E S Orwoll
A double-blind, randomized comparative trial of amisulpride versus olanzapine for 6 months in the treatment of schizophrenia.
March 2004, International clinical psychopharmacology,
M D Hornstein, and A A Yuzpe, and K A Burry, and L R Heinrichs, and V L Buttram, and E S Orwoll
Injection of dexamethasone versus placebo for lateral elbow pain: a prospective, double-blind, randomized clinical trial.
January 2008, The Journal of hand surgery,
M D Hornstein, and A A Yuzpe, and K A Burry, and L R Heinrichs, and V L Buttram, and E S Orwoll
Nafarelin in the treatment of pelvic pain caused by endometriosis.
February 1990, American journal of obstetrics and gynecology,
M D Hornstein, and A A Yuzpe, and K A Burry, and L R Heinrichs, and V L Buttram, and E S Orwoll
Randomized trial of leuprolide versus continuous oral contraceptives in the treatment of endometriosis-associated pelvic pain.
April 2011, Fertility and sterility,
M D Hornstein, and A A Yuzpe, and K A Burry, and L R Heinrichs, and V L Buttram, and E S Orwoll
Dienogest in the treatment of endometriosis-associated pelvic pain: a 12-week, randomized, double-blind, placebo-controlled study.
August 2010, European journal of obstetrics, gynecology, and reproductive biology,
M D Hornstein, and A A Yuzpe, and K A Burry, and L R Heinrichs, and V L Buttram, and E S Orwoll
A randomized, placebo-controlled, double-blind study of hysteroscopic-guided pertubal diluted bupivacaine infusion for endometriosis-associated chronic pelvic pain.
September 2015, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics,
Copied contents to your clipboard!